Arcadia Biosciences (RKDA) Reports Q2 Loss Per Share of $0.19

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($0.19), versus ($3.08) reported last year. Revenue for the quarter came in at $1.43 million, versus $1.31 million reported last year.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
• Isabella Bank added to Russell 2000 index after Nasdaq listing
• Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue